The GenomEra® C. difficile assay, performed on the GenomEra® CDX system, is a qualitative in vitro diagnostic (IVD) nucleic acid test for the detection of toxin B producing Clostridium difficile in liquid or unformed stool samples. The test utilizes automated homogeneous polymerase chain reaction (PCR) to detect the tcdB gene which encodes the C. difficile toxin B, ensuring comprehensive coverage of the virulent C. difficile strains.
Also available in a 40 test kit size including 1 μl inoculation loops.
The GenomEra® CDX system from Uniogen provides a powerful tool to run DNA testing routinely and cost-efficiently without compromising the quality of results and reliability. All...
The GenomEra® C. difficile assay, performed on the GenomEra® CDX system, is a qualitative in vitro diagnostic (IVD) nucleic acid test for the detection of toxin B producing...
To be run with the GenomEra® Clostridium difficile assays
The GenomEra® Norovirus assay, performed on the GenomEra® CDX Instrument, is a qualitative in vitro diagnostic (IVD) nucleic acid test intended for the detection and...
The GenomEra® GBS assay, performed on the GenomEra® CDX system, is a qualitative in vitro diagnostic (IVD) nucleic acid test for the detection of group B Streptococcus...
